Moderna
MRNA
#221
Rank
A$149.21 B
Marketcap
A$368.78
Share price
5.27%
Change (1 day)
867.84%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -A$4.46 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.21 Billion. In 2025 the company made an earning of -A$4.01 Billion, an increase over its 2024 earnings that were of -A$5.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$4.46 Billion11.26%
2025 -A$4.01 Billion-23.03%
2024 -A$5.2 Billion-8.22%
2023 -A$5.67 Billion-140.65%
2022 A$13.93 B-27.81%
2021 A$19.29 B-1911.15%
2020 -A$1.07 Billion44.7%
2019 -A$0.74 Billion28.63%
2018 -A$0.58 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.16 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.34 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$11.15 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$68.81 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$60.59 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.77 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.24 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA